Generic Drugs Vaneck ETF
(GNRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNRX | ||||
| Company | Generic Drugs Vaneck ETF | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 22.17 | ||||
| High | 22.42 | ||||
| Low | 22.17 | ||||
| Latest | 22.42 | ||||
| Change | -0.01 | ||||
| % Change | -0.06% | ||||
| Volume | 3,300 | ||||
| 20-Day Average Volume | 755 | ||||
| Previous Close | 22.43 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 22.20 | ||||
| 20-Day Raw Stochastic | 80.85% | ||||
| 20-Day Relative Strength | 51.60 | ||||
| Weighted Alpha | -11.10 | ||||
| Today's Opinion | 40% Sell | ||||
| Previous Opinion | 40% Sell | ||||
| Last Month's Opinion | 88% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.83% since 03/28/19 | ||||
| Low | 22.11 on 03/29/19 | ||||
| High | 22.43 on 04/01/19 | ||||
| 1-Month | |||||
| %Chg | +0.66% since 03/01/19 | ||||
| Low | 21.80 on 03/28/19 | ||||
| High | 22.56 on 03/21/19 | ||||
| 3-Month | |||||
| %Chg | +6.95% since 01/04/19 | ||||
| Low | 21.17 on 01/07/19 | ||||
| High | 22.56 on 03/21/19 | ||||
| 6-Month | |||||
| %Chg | -10.05% since 10/04/18 | ||||
| Low | 20.17 on 12/27/18 | ||||
| High | 24.38 on 10/08/18 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 3,358 | ||||
| Shares Outstanding, K | 150 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 1.12 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | 12/20/18 | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||